← Eichor
Study identifier: NCT07318987 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

EFFECT OF SAPHENOUS NERVE RELEASE ON PATIENTS WITH PATELLOFEMORAL PAIN SYNDROME

Condition: Patellofemoral Pain Syndrome  ·  Sponsor: Cairo University

PhaseNA
Planned participants36
Who can joinAll sexes, 18 Years to 35 Years
Healthy volunteersNo

About this study

Patellofemoral Pain Syndrome (PFPS) is a frequent cause of anterior knee pain in young, physically active individuals, especially females, and is commonly managed with quadriceps and hip-focused exercises. However, the role of neural factors has been largely overlooked. The saphenous nerve, which supplies sensation to the anteromedial knee, may become irritated or entrapped and contribute to pain and neuromuscular dysfunction in PFPS. This study suggests that manual therapy targeting the saphenous nerve could improve pain, function, and balance, providing a more holistic approach to PFPS rehabilitation.

This description comes directly from the study's public registry record.

Talk to the study team

Markos Boshra, bachelor's  ·  01201365245  ·  markosboshra3@gmail.com

Markos Boshra, bachelor's  ·  01550799147  ·  markosboshra3@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Faculty of Physical Therapy, Cairo UniversityCairo, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07318987